Alixia is a startup based in the United States. Brouky records 1 investor associated with the company.
Alixia develops therapeutics targeting the tumor microenvironment to overcome cancer drug resistance by disrupting metabolic and inflammatory interactions within tumor ecosystems.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.